Halis Akalın
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antifungal resistance and susceptibility 22
- SARS-CoV-2 and COVID-19 Research 6
- Epidemiology 32
- Fungal Infections and Studies 11
- Co-authors
- Beyza Ener (34 shared papers)Suna Gedikoğlu (9 shared papers)Haluk Barbaros Oral (18 shared papers)S Helvaci (5 shared papers)Cüneyt Özakın (25 shared papers)Emel Yılmaz (22 shared papers)Güher Göral (7 shared papers)Ferah Budak (13 shared papers)
- Journals
- Mycoses (5 papers)Journal of Chemotherapy (3 papers)International Journal of Infectious Diseases (3 papers)Journal of the International AIDS Society (2 papers)Scientific Reports (2 papers)
- Partner nations
- TürkiyeNetherlandsCanada
In The Last Decade
Halis Akalın
98 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 108
- Applied Microbiology and Biotechnology 80
- Molecular Medicine 205
- Infectious Diseases 530
- Small Animals 162
- Otorhinolaryngology 81
Countries citing papers authored by Halis Akalın
This map shows the geographic impact of Halis Akalın's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halis Akalın with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halis Akalın more than expected).
Fields of papers citing papers by Halis Akalın
This network shows the impact of papers produced by Halis Akalın. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halis Akalın. The network helps show where Halis Akalın may publish in the future.
Co-authors
The 25 scholars most cited alongside Halis Akalın, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 121 | |
| 2 | 2006 | 91 | |
| 3 | 2006 | 89 | |
| 4 | 2010 | 85 | |
| 5 | 2009 | 81 | |
| 6 | 2006 | 79 | |
| 7 | 2021 | 67 | |
| 8 | 2001 | 65 | |
| 9 | 2015 | 48 | |
| 10 | 2018 | 44 | |
| 11 | 2005 | 44 | |
| 12 | 2019 | 42 | |
| 13 | 2004 | 38 | |
| 14 | 2015 | 37 | |
| 15 | 1999 | 36 | |
| 16 | 2015 | 36 | |
| 17 | Pneumonia after kidney transplant: incidence, risk factors, and mortality. | 2014 | 34 |
| 18 | 2005 | 32 | |
| 19 | 2014 | 29 | |
| 20 | 2009 | 26 |
About Halis Akalın
Halis Akalın is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Small Animals and Immunology, having authored 109 papers that have together received 1.8k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (22 papers), Antibiotic Resistance in Bacteria (14 papers), Fungal Infections and Studies (11 papers), Antibiotic Use and Resistance (11 papers), Brucella: diagnosis, epidemiology, treatment (9 papers), Galectins and Cancer Biology (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (80 citations), Molecular Medicine (205 citations), Infectious Diseases (530 citations), Small Animals (162 citations) and Otorhinolaryngology (81 citations). Halis Akalın has collaborated with scholars based in Türkiye, Netherlands and Canada. Frequent co-authors include Beyza Ener, Suna Gedikoğlu, Haluk Barbaros Oral, S Helvaci, Cüneyt Özakın, Emel Yılmaz, Güher Göral, Ferah Budak, Esra Kazak and Ferda Kahveci. Their work appears in journals such as Mycoses, Journal of Chemotherapy, International Journal of Infectious Diseases, Journal of the International AIDS Society and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.